Non-Human Primate (NHP) Applications by Research Stage

Are you currently facing long drug development cycles, complex clinical trials, or challenges in obtaining high-quality, translational data? Creative Biolabs helps you accelerate your preclinical research and streamline your path to IND submission through advanced nonhuman primate (NHP) models and comprehensive, full-service support. Our expertise and capabilities provide the critical link between basic research and human clinical application.

Utilizing NHP Models Across Research Phases: Connecting Preclinical Insights to Clinical Breakthroughs.

Our NHP models are strategically integrated at critical junctures of a multi-stage process to provide the most relevant, human-like data, reducing the risk of failure and accelerating your program's progress.

Get a Quote

Overview of NHP Applications

What Are Our Research Areas?

Early Discovery & PoC: At this foundational stage, the focus is on generating robust proof-of-concept data. Our services provide critical insights into a drug candidate's mechanism of action, preliminary efficacy, and initial safety profile in a highly translatable system. This early-stage data is crucial for de-risking your pipeline and making informed go/no-go decisions.
IND-Enabling Translation: This is the pivotal phase where a therapeutic transitions from preclinical to clinical development. We provide comprehensive safety and toxicology studies that satisfy regulatory requirements. The data we generate on PK, PD, and potential immune responses in NHPs are essential for your IND application.
Immunology & Biomarker Research: The intricate human-like immune systems of NHPs make them the ideal model for immunotherapeutic development. Our services focus on characterizing a drug's immune-mediated effects, identifying key biomarkers, and understanding on-target and off-target responses. This research is vital for predicting potential cytokine release syndromes and ensuring patient safety.
Long-Term Monitoring: For advanced therapies like gene and cell therapies, long-term data on durability, safety, and vector shedding are critical. We offer longitudinal studies to track the persistence of therapeutic effect, monitor for any late-onset toxicities, and provide the comprehensive data required for regulatory post-market commitments.

Why Choose Us?

The unique biological similarities between NHPs and humans make them an essential model for modern drug development.

Genetic/Immunological Similarities: NHPs share a high degree of genetic and immunological similarity with humans, making them the most predictive preclinical model for complex diseases and immunotherapies.
Clinical Translational Relevance: Data from NHP studies are highly regarded by regulatory bodies as they provide the best available evidence of a drug's likely behavior in humans, bridging the gap between animal and human studies.
Data Types Required for Regulatory Submissions: Our studies are specifically designed to generate the PK, PD, safety, and toxicology data required for IND and other regulatory submissions, ensuring your program's compliance and smooth progression.

Key Applications

NHPs are critical in modeling diseases and evaluating therapies that cannot be adequately studied in other animal models. Their use provides actionable insights for complex therapeutic areas:

Gene & Cell Therapy: NHP models are used for vector biodistribution and shedding studies, providing essential data on where a viral vector travels in the body and for how long it persists. They are also used to assess the safety and efficacy of cell therapies like CAR-T, particularly in evaluating the potential for cytokine release syndrome (CRS) and other immune-related adverse events.
Oncology & Immunotherapy: NHPs enable the study of complex immune checkpoint inhibitors (ICIs) and other immunomodulatory agents. They are used to model the tumor microenvironment and evaluate a drug's ability to modulate immune cells, providing critical data on efficacy and on-target effects.
Infectious Diseases & Vaccines: The close immunological match between NHPs and humans makes them the gold standard for developing and testing vaccines for both established and emerging infectious diseases. They are used to evaluate vaccine immunogenicity and protection, as well as to study viral pathogenesis.

How Do Creative Biolabs Support Your Projects?

At Creative Biolabs, we provide a full suite of services to support your NHP research needs from start to finish. Our capabilities are designed to provide the high-quality, regulatory-compliant data necessary for a successful IND application.

Service Capability	Corresponding Application Area
Bioanalysis & Biomarker	These services are critical for all research stages, from early-stage PK/PD to IND-enabling toxicology studies.
Safety & Toxicology	These studies provide essential safety data for small molecules, biologics, and advanced therapies, which is crucial for IND-enabling translation.
Pharmacology & Efficacy	This capability is central to generating proof-of-concept data for early discovery and validating therapeutic strategies for late-stage development.
Biological Collection & Biobanking	This foundational service supports all stages of research, providing the necessary samples for bioanalysis, biomarker studies, and long-term monitoring.

Translational Impact

Our NHP research services provide more than just data; they provide the translational bridge needed for regulatory success. The data generated in our NHP models provides more reliable early proof of concept, helps in the early detection of immune responses and toxicity, and ultimately reduces the risk of costly IND failure. NHP biodistribution data, for instance, is often a specific requirement from regulatory agencies for gene therapy IND submissions, directly impacting your ability to move to clinical trials.

Frequently Asked Questions

Q: How do you ensure the quality of your NHP models and biospecimens?

A: We source all NHPs from accredited colonies with detailed health and genetic histories. Our biospecimen bank adheres to rigorous collection and quality control protocols to ensure sample integrity and stability.

Q: Can you help us design a study that meets specific regulatory requirements?

A: Absolutely. Our scientific team has extensive experience in designing studies that meet the specific needs of regulatory agencies. We work closely with you to create a protocol that addresses your program's unique requirements and ensures the data generated is IND-enabling.

Q: How do NHP studies compare to rodent studies, and when should we use an NHP model?

A: While rodents are valuable for certain types of basic research, NHPs are often the only model capable of providing clinically relevant data for complex therapies due to their physiological and immunological similarities to humans. An NHP model is typically required when your therapeutic targets a human-specific pathway or when a human-like immune response needs to be characterized.

Q: Is it possible to conduct a small-scale study to evaluate your services before committing to a larger program?

A: Yes. We offer a variety of customizable pilot studies and feasibility assessments. This allows you to evaluate our capabilities and the translatability of your therapeutic candidate in our models before committing to a full-scale IND-enabling program. Please contact us to discuss your specific needs.

Contact Us

Creative Biolabs provides the expertise, models, and comprehensive services required to navigate the complexities of preclinical research and accelerate your therapeutic from the lab to the clinic. Ready to leverage our NHP applications for your next study? Contact our team of experts for a detailed discussion about your project and to request a personalized quote.